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Abstract— Pathway optimization is, in general, a very 
demanding task due to the complex, nonlinear and largely 
unknown interactions of enzymes, regulators and metabolites. 
While in vitro reconstruction and pathway analysis is a viable 
alternative, a major limitation of this approach is the availability 
of the pathway enzymes for reliable pathway reconstruction. 
Here, we report the application of RNA display methods for the 
construction of fusion (chimeric) molecules, comprising mRNA 
and the protein they express, that can be used for the above 
purpose. The chimeric molecule is immobilized via hybridization 
of its mRNA end with homologous capture DNA spotted on a 
substrate surface. We show that the protein (enzyme) end of the 
fusion molecule retains its function under immobilized conditions 
and that the enzymatic activity is proportional to the amount of 
capture DNA spotted on the surface of a microarray or 96-well 
microplate. The relative amounts of all pathway enzymes can thus 
be changed at will by changing the amount of the corresponding 
capture DNA. Hence, entire pathways can be reconstructed and 
optimized in vitro from genomic information alone by generating 
chimeric molecules for all pathway enzymes in a single in vitro 
translation step and hybridizing on 96-well microplates where 
each well contains a different combination of capture DNA. We 
provide validation of this concept with the sequential reactions 
catalyzed by luciferase and nucleoside diphosphate kinase and 
further illustrate this method with the optimization of the 
five-step pathway for trehalose synthesis. Multi-enzyme pathways 
leading to the synthesis of specialty molecules can thus be 
optimized from genomic information about the pathway enzymes, 
provided the latter retain their activity under the in vitro 
immobilized conditions.. 
 
Index Terms—functional protein chip, in vitro metabolic 
engineering, combinatorial pathway optimization, trehalose 
synthesis. 
 
I. INTRODUCTION 
The properties of metabolic pathways uniquely depend on the relative activities of all the enzymes that they comprise. 
As such, metabolic pathways can be optimized by 
manipulating the relative expression of the corresponding 
genes such as to maximize the amount of a specialty product 
that they synthesize or to minimize an undesirable metabolite 
associated with disease. Pathway optimization through the 
introduction of genetic controls is indeed a central tenet of 
metabolic engineering1. However, despite recent advances in 
pathway optimization and metabolic engineering2-5, this 
remains a very demanding undertaking due to the complexity 
of metabolic pathways and the difficulty in obtaining sufficient 
measurements about the intracellular environment. Popular 
methods, such as single gene over-expression or 
over-expression of all pathway genes, are optimal strategies 
only in special cases, suggesting the need for a holistic 
approach to this problem. Mathematical theories are 
sufficiently developed to yield rational solutions to pathway 
optimization provided that satisfactory kinetic models are 
available for the pathway reactions. However, their use has 
been rather limited exactly because reliable models of in vivo 
pathway function are mostly unavailable. As a result, pathway 
optimization must rely on experimental methods of 
combinatorial search nature, whereby the relative amounts (or 
activities) of the pathway enzymes are altered and the effect on 
the pathway performance is measured. In principle, this would 
be a viable option, especially in light of recent advances in the 
miniaturization of experimental searches of this type 6-9, except 
for the general enzyme unavailability in pure and active form 
for reconstructing the pathway of interest.  
mRNA-protein fusions, originally developed for use in RNA 
display 10, are molecules linking covalently an expressed 
mRNA and its translated protein product. As such, these fusion 
molecules (Fig. 1a) comprise two distinct parts. One, (mRNA), 
carrying genetic information that can be used as unique and 
specific tag complement for capturing the fusion molecule by a 
homologous capture DNA, and another (protein) that is 
endowed with potential functionality. If the capture DNA is 
immobilized on a solid support, it could be used as anchor for 
attaching the entire chimeric molecule on the support. The 
specificity of the mRNA-DNA hybridization suggests that a 
particular chimeric molecule could be recognized in a mixture 
of similar molecules and specifically attached to a particular 
space of a solid support (Fig. 1b). In this case, the number of 
fusion molecules immobilized should be proportional to the 
amount of DNA capture molecules attached on the support. 
Once a fusion molecule is immobilized by hybridization, the 
protein end of it would be available for carrying out its usual 
functions provided that it retained its activity under  
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II. MATERIALS AND METHODS 
  
A. Preparation of mRNA-protein fusion molecules 
mRNA-protein fusion molecules were synthesized by the 
method reported by Roberts and Szostak10  with a modification. 
Each RNAs were splint-ligated to the puromycin-oligo DNA 
linker [5'-d(A27CC)-P] possessing a 5'-phosphate and a 
3'-puromycin by T4 DNA ligase (P in the above sequence 
denotes puromycin). Ligation products were purified by gel 
extraction and in vitro translated in rabbit reticulocyte lysate 
system purchased from Ambion (Austin, TX). After 90 min 
translation, the reaction mixture was adjusted to 150 mM 
MgCl2 and 425 mM KCl to promote the formation of the 
puromycin-peptide bond. 
B. Preparation of functional protein chip 
Proper amounts of capture DNAs designed for specific, 
non-interacting sequences along the target RNAs were spotted 
on poly-lysine coated surface of 96-microwell plate (BD 
Biosciences Clontech, Palo Alto, CA) and crosslinking was 
carried out under UV light in UV crosslinker (Stratagene, La 
Jolla, CA). Capture DNA molecules were synthesized from 
Integrated DNA Technologies Inc. (Coralville, IA) as follows:  
  
luciferase : 5'AGCCTTATGCAGTTGCTCTC3' Fig. 1. (a) Schematic of the mRNA-protein fusion molecule used for RNA 
display applications and employed in this study. mRNA-protein fusion 
molecules were synthesized by in vitro translation system derived from rabbit 
reticulocyte. (b) Illustration of the method employed in the construction of 
functional protein chips using mRNA-protein fusion chimeras and their 
homologous capture DNA molecules 
ndk : 5'TCTCTTTCAGCACTTTCCTT3' 
udpgp : 5’GCGCTGCTCAAGGAGTGATT3’ 
hxk1 : 5’CAACTTTTCGATATCGGAAA3’ 
pgm : 5’CGTCTTTATCAAGGTGCATA3’ 
 otsA : 5’CAAGAACGCCCGGATTGGCT3’ 
 otsB : 5’TCACCTTTACTGGTACCTCT3’ 
.immobilized conditions.   
 A mixture of mRNA-protein fusion molecules is synthesized 
in a single vial by in vitro transcription-translation. The mixture 
is subsequently applied to microplate wells whose surface 
contains capture DNA molecules. Following prehybridization 
with 1 % ultra-pure bovine serum albumin (Ambion, Inc., 
Austin, TX), fusion molecules are specifically hybridized with 
their corresponding capture DNA molecules. Residual fusion 
molecules are washed out from the well by washing twice with 
1X PBS buffer (pH 7.6). After refreshing with a proper reaction 
buffer in the well, the enzymes immobilized on the surface are 
ready to catalyze the reaction. The relative amounts of capture 
DNA molecules immobilized on the surface of the wells 
determine the relative activity of the enzymes in the well. 
Weng et al. 11 recently demonstrated that mRNA-protein 
fusion molecules could be hybridized on a DNA microarray to 
build a protein microarray. Using three different types of 
proteins and their tagged antibodies it was shown that 
mRNA-protein fusion molecules could specifically bind to 
their corresponding capture DNA. In this study, we employed 
this platform for catalytically active proteins in order to 
reconstruct metabolic pathways whose enzymes were not 
readily available. A novel feature of this work is the parallel 
generation of all mRNA-enzyme fusion molecules in a single in 
vitro translation step. The relative amounts of the different 
types of fusion molecules immobilized on the wells of a 
96-well microplate were controlled by the amounts of unique 
capture DNA molecules designed for each target enzyme. A 
key finding is that all seven mRNA-enzyme fusions examined 
retained their catalytic activity under immobilized conditions. 
The main result is that this arrangement facilitated the 
experimental investigation of numerous combinations of 
relative enzyme activities and ultimately the optimization of the 
five-step pathway for trehalose synthesis. Other combinations 
of relative enzyme activities were clearly suboptimal yielding 
inferior overall pathway performance.  
C. Enzymatic Reactions 
A sequential reaction catalyzed by nucleoside diphosphate 
kinase (NDK) and luciferase was carried out based on the 
method developed by Karamohamed et al.12 50 µl of reaction 
buffer containing the following components: 0.1 M Tris-acetate 
(pH 7.75), 2 mM EDTA, 10 mM magnesium acetate, 0.1 % 
BSA, 1 mM dithiotreitol (DTT), 0.4 mg/ml 
polyvinylpyrrolidone (360,000), 100 µg/ml D-luciferin. 
Reaction was performed at room temperature for 1 hr and the 
resulting luminescence was measured by FusionTM microplate   
 
 
 
III. RESULTS AND DISCUSSION 
Fig. 2. The efficiency of crosslinking and hybridization. (a)
Crosslinking efficiency. Fluorescein-labeled luciferase capture DNA
was crosslinked in UV crosslinker as described in Materials and
Methods. Fluorescence was measured by FusionTM microplate reader
(Perkin Elmer, Co., Wellesley, MA). Arbitrary unit was used for
fluorescence. (b) Hybridization efficiency. Hybridization process was
carried out in the well with 5 µg of luciferase capture DNA described in
Materials and Methods. For the suspended version, same hybridization
process was carried out on the well without capture DNA to avoid the
effect of hybridization process. After hybridization, luciferase
activities were measured under the condition described in Materials
and Mathods. 
A. Efficiency of capture DNA crosslinking 
Fluorescein-labeled oligonucleotides coding luciferase 
capture DNA synthesized from Integrated DNA technologies, 
Inc. (Coralville, IA) were loaded on the well coated by 
poly-lysine and crosslinking was carried out in the UV 
crosslinker (Stratagene, La Jolla, CA). After crosslinking, wells 
were washed twice with 200 µl of 1X PBS solution and 
negligible fluorescence was found from the washed solution up 
to 100 µg. However, slight fluorescence from washed solution 
was observed over 100 µg of DNA. This indicates that 
poly-lysine coated microwell can immobilize up to 100 µg of 
DNA. Fluorescein tags were relieved from the surface by 
treating DNase and measure their fluorescence compared with 
the same amount of fluorescein-labeled capture DNA loaded 
(Fig. 2a). Almost 100 % crosslinking efficiency can be found 
up to 100 µg and DNA was saturated at 100 µg. 
The activity of hybridized luciferase fusion molecule 
was compared with that of suspended one (Fig. 2b). In order to 
avoid the effect of hybridization, luciferase fusion molecules 
were loaded on the well free from capture DNA and carried out 
the same hybridization process as described in Materials and 
Methods. The activities of the hybridized fusion molecules on 
the surface were found as similar with the equivalent amount of 
fusion molecules in the solution, which indicated that the 
immobilization does not affect on the activity of fusion 
molecules. 
 
B. A sequential reaction by NDK and luciferase 
We first sought to validate the basic premises of this 
approach, i.e., (a) that chimeric molecules hybridize on 
homologous DNA attached to a solid support, (b) that the 
enzyme end of the chimera retains its activity when attached to 
the support, and, (c) that enzymatic activity is proportional to 
the amount of capture DNA spotted on the solid support. The 
sequential reaction catalyzed by nucleotide diphosphate kinase 
(NDK) and luciferase was used for this purpose as a model 
system 12: reader (Perkin Elmer, Co., Wellesley, MA). One light unit defined as an amount of enzyme producing a biometer peak 
height equivalent to 0.02 µCi of 14C in PPO/POPOP cocktail. 
Light units measured in 50 µl assay mixture containing 5 µmol 
ATP and 7.5 µmol luciferin in Tris-glycine buffer, pH 7.6, at 25 
ºC. The correlation between the light unit and luminescence 
was determined by using the authentic luciferase purchased 
from Sigma-Aldrich (St. Louis, MO). 
 
 
 
ADP + GTP → ATP + GDP  (catalyzed by NDK, 
Reaction 1)  
ATP + D-luciferin + O2 → ADP + oxyluciferin + light            
(luciferase, Reaction  2)   Trehalose synthesis was carried out in the buffer containing 
50 mM Tris-Cl (pH 7.6), 10 mM magnesium chloride, 110 mM 
glucose, 55 mM ATP, 16.7 mM UTP, and 16.7 µg/ml 
glucose-1,6-bisphosphate for 3 hr at 30 ºC. Synthesized 
trehalose was measured using the method with acid trehalase13. 
mRNA-enzyme fusion molecules were synthesized in the 
modified in vitro translation system from rabbit reticulocyte 
lysate and were loaded on the wells of a 96-well microplate 
each containing different amounts of DNA capture molecules 
for the two enzymes, NDK and luciferase as described in 
Materials and Methods.  
 
Fig. 3 summarizes the results obtained when different 
amounts of a particular type of capture DNA in the wells were 
used with different volumes of load solution obtained from the 
in vitro translation of individual fusion molecules (henceforth 
 
 
termed “solution”).  For the same solution volume (i.e., same 
amount of fusion molecules), Fig. 3a shows that the activity of 
each reaction increases and then saturates as the amount of 
capture DNA spotted on the wells increases. Apparently 0.3 µg 
of capture DNA is sufficient to hybridize all fusion molecules 
produced by in vitro translation of luciferase or NDK. When 
the amount of capture DNA is fixed at the maximum of 0.3 µg, 
the activity of each enzyme increases linearly (up to 40 µl of 
solution) with the amount of solution loaded on the well, (Fig. 
3b). Next, we wished to investigate the specificity of 
hybridization when fusion molecules of both enzymes were 
present in the solution. To this end, mixtures of fusion 
molecules (all translated in a single step) were loaded on wells 
containing different combinations of the two types of capture 
DNA. Fig. 3c shows the activity of luciferase in wells 
containing varying amounts of luciferase capture DNA 
molecule and the same amount (0.3 µg) of NDK capture DNA. 
Similarly, Fig 2d shows the activity of NDK in wells containing 
varying amounts of NDK capture DNA and the same amount 
(0.3 µg) of luciferase capture DNA. In both cases the same 
amount of solution was used containing both types of fusion 
molecules. The linear dependence seen in both cases is 
evidence for the specificity of the hybridization between fusion 
molecules and capture DNA, as well as the activity of each 
fusion enzyme of the consecutive reaction system of equations 
(1) and (2). A replica set of reactions with RNase-treated fusion 
molecules showed no activity at all, evidence of the critical role 
played by the mRNA portion of the fusion molecule in 
capturing the enzymatic activity.  
The above results demonstrate the two advantages of the 
described approach. First, reaction mixtures containing all 
types of fusion molecules can be directly applied to the well 
without any purification. Only a single step of in vitro 
translation is required to generate all fusion molecules that are 
subsequently separated by specific hybridization in amounts 
(and locations) controlled by the homologous capture DNA 
Fig. 3. Activity and specificity of the mRNA-Enzyme chimeras immobilized by homologous recombination with capture DNA molecules attached on a 
microwell surface. The sequential reaction of luciferase and nucleoside diphosphate kinase (NDK) was used as test system: (a) Effect of increasing amounts of 
capture DNAs on enzymatic activities. 30 µl of fusion molecules solution were loaded in each well. (b) Effect of increasing amounts of fusion molecules on 
enzymatic activities with 0.3 µg of capture DNA molecules spotted on each well. (c) Specificity of hybridization between fusion molecules and capture DNA.
Mixtures of fusion molecules (all translated in a single step) were loaded on wells containing different combinations of the two types of capture DNA. Shown are 
the activity of luciferase in wells containing varying amounts of luciferase capture DNA molecule and the same amount (0.3 µg) of NDK capture DNA and the 
activity of NDK in wells containing varying amounts of NDK capture DNA and the same amount (0.3 µg) of luciferase capture DNA. In both cases the same 
amount of solution was used containing both types of fusion molecules. Closed and open symbols represent luciferase and NDK, respectively. 
 
 
molecules. Second, processing time is minimized for 
immobilizing the enzymes on supports at numerous 
combinations suitable for high throughput testing. 
C. Optimization of trehalose synthesis pathway 
While the two-step pathway of reactions (1) and (2) 
yielded encouraging results, for broader use, it is necessary that 
the applicability of the above platform be demonstrated with a 
realistic pathway exhibiting the network and regulatory 
complexities present in real metabolic bioreaction networks. To 
this end, we selected the trehalose synthesis pathway from 
glucose (Fig. 4h). Trehalose is a disaccharide with a large 
potential market as a multi-functional sweetener, moisture 
retainer in cosmetics and preservative in pharmaceutical 
products and frozen foods, among others.14 It is synthesized in 
yeast and has also been observed in bacterial fermentation 
products.15,16 The pathway of trehalose synthesis harbors a 
branch point (glucose-6-phosphate) where flux distributions 
between two competing reactions can materially impact 
end-product accumulation. Additionally, very little is known 
about the kinetics and regulation of the five reactions of the 
pathway, only one of the enzymes is commercially available, 
and overabundance of any single enzyme or all five together 
does not yield an optimal system in terms of maximal trehalose 
accumulation rate. It is therefore of interest to determine the 
optimal profile of relative enzymatic activities, or relative gene 
expression rates for an in vivo application, that would maximize 
the rate of this pathway. 
Fig. 4. Systematic optimization of the trehalose synthesis pathway using the functional protein chip of this study. Total trehalose was determined at 3 hr after
initiation of reaction (23). The effect of varying amounts of each pathway enzyme on trelahose synthesis was examined while keeping the other enzymes fixed 
at (a) 3 µg, (b) 4 µg, and (c) 5 µg based on capture DNA molecules. As the optimal amount of OtsA was determined at 4 µg, further experiments were carried 
out with 4 µg of OtsA while the other enzymes were fixed at the levels of, (d) 6 µg and (e) 7 µg in terms of capture DNA molecules. (f) Effect of varying 
enzyme amounts on trehalose synthesis under the optimal condition (4 µg of OtsA and 6 µg of PGM) with the other enzymes were set at 8 µg in terms of 
capture DNA. (g) Amount of trehalose product synthesized for varying amounts of total PGM and OtsA maintained at the optimal ratio of 3/2. Other enzymes
were saturated at 8 µg based on capture DNA in each reaction mixture. (h) Schematic of the trehalose synthesis pathway used in this study. All the genes were 
cloned from the E. coli K12 genomic DNA except for hxk1 cloned from Saccharomyces cerevisiae by polymerase chain reaction using the primers described 
Table I. 
 
 
 
 
 
In lieu of a complete combinatorial search, we 
systematically explored the kinetics of the trehalose pathway as 
follows: First, we examined the effect of each enzyme on 
trehalose synthesis by setting the amounts of all but one 
enzyme at a constant level and measuring the rate of trehalose 
synthesis as the amount of the enzyme of interest was increased 
from zero to the same level as the other four enzymes (We did 
not actually measure the activities of the five enzymes; their 
actual amounts and activities were controlled by the amount of 
the corresponding homologous capture DNA that was spotted 
on the well of the 96-well microplate.). This was done with 
each of the five pathway enzymes and the entire process was 
repeated for a higher enzyme level. Each curve in Fig. 4a shows 
the amount of trehalose synthesized over a 3-hour period when 
the amounts of all but one enzyme are set at the maximum 
captured by 3 µg of spotted capture DNA and the amount of the 
fifth is varied between 0 and 3 µg.  Figs. 4b and 4c show the 
trehalose amounts obtained in similar experiments where the 
maximum enzyme amounts were set by 4 µg and 5 µg of 
capture DNA, respectively. It can be seen that, while saturation 
profiles are obtained for the lower enzyme amounts, a trehalose 
synthesis rate maximum is observed, (Fig. 4c), when the 
maximum enzyme is set by 5 µg of capture DNA for all four 
enzymes except trehalose-6-phosphate synthase (OtsA). The 
maximum trehalose synthesis rate occurs when OtsA is at the 
amount determined by 4 µg of OtsA capture DNA. Figs. 4d and 
3e show the product amounts obtained when OtsA is set by the 
optimum of 4 µg of its capture DNA and the amount of the 
other enzymes is similarly increased to 6 µg and 7 µg of capture 
DNA, respectively. In these graphs, trehalose productions are 
found to be elevated compared to the previous one shown in 
Fig. 3c from three curves corresponding to hexokinase 
(HXK1), UDP-glucose pyrophosphrylase (UDPGP) and 
trehalose-6-phosphate phosphatase (OtsB). In these three 
cases, the level of OtsA was set by 4 µg of capture DNA 
yielding the maximum trehalose production which seemed to 
enhance the trehalose flux even for the low concentration 
range. The optimized OtsA, however, did not affect the curve 
for PGM, and this can be evidence that PGM is another limiting 
step for trehalose production. We observe that, while a 
monotonic response is obtained for the three enzymes of 
hexokinase (HXK1), UDP-glucose pyrophosphorylase 
(UDPGP) and trehalose-6-phosphate phosphatase (OtsB), the 
trehalose amount is maximized at 6 µg of capture DNA for 
phosphoglucomutase (PGM) (Fig. 4e). Each curve in Fig. 3f 
shows the trehalose product obtained when the amount of the 
corresponding enzyme is varied between 0 and 8 µg while the 
three enzymes, HKK1, UDPGP and OtsB are kept at the 
maximum of 8 µg of capture DNA, and OtsA and PGM are set 
at the optimal levels captured by 4 and 6 µg of spotted DNA 
respectively. In summary, for the enzyme levels examined, 
increasing the amounts of the three enzymes, e.g., HXK1, 
UDPGP, and OtsB, enhances trehalose synthesis as evidenced 
by the monotonic increase of the trehalose amounts obtained 
with increasing amounts of the corresponding capture DNA. 
On the other hand, PGM and OtsA have optimal activities at 
which they must be maintained for maximum trehalose 
synthesis.  
TABLE I 
PRIMERS USED FOR PCR TO CLONE THE GENES IN TREHALOSE SYNTHESIS 
PATHWAY 
Gene Primers 
udpgp Psense: 5’ATGACGAATTTAAAAGCAGT3’ 
 Pantisense: 5’GAGCTCTTATTCGCTTAACAGCTTCT3’ 
hxk1 Psense: 5’ATGGTTCATTTAGGTCCAAA3’ 
 Pantisense: 5’AGTACTAGCGCCAATGATACCAAGAG3’ 
pgm Psense: 5’ATGGCAATCCACAATCGTGC3’ 
 Pantisense: 5’GAGCTCCGCGTTTTTCAGAACTTCGC3’ 
otsA Psense: 5’ATGAGTCGTTTAGTCGTAGT3’ 
 Pantisense: 5’AGTACTCGCAAGCTTTGGAAAGGTAG3’ 
otsB Psense: 5’GTGACAGAACCGTTAACCGA3’ 
 Pantisense: 5’AGTACTATACTAACGACTAAACGACTC3’ 
 
 
We note that PGM and OtsA are enzymes at the branch 
point of the pathway and maintaining an optimal balance of 
their activities is the key for optimal flux allocation. Too high 
of PGM activity will drain the pool of glucose-6-phosphate 
required in the condensation reaction catalyzed by OtsA. 
Similarly, too high activity of OtsA cannot be supported by the 
available pool of UDP-Glucose unless an optimal activity of 
PGM is also present. As shown in Figs. 3a and 3b, no optimal 
amounts of PGM and OtsA are found, indicating that, at these 
levels, the activities of both enzymes were too low to deplete 
the pool of glucose-6-phosphate. Throughout all experiments 
conducted with various enzyme amounts (Fig 4c – 4f), 
trehalose synthesis is maximized when the three enzymes 
(HXK1, UDPGP and OtsB) are maintained at maximum 
activity while the activity of PGM and OtsA is controlled at the 
optimal ratio of 3/2. This finding was tested in a subsequent 
experiment in which the total amount (and therefore activity) of 
PGM and OtsA was varied from 0 to 15 µg while maintaining 
the optimal ratio of 3/2 and with the other three enzymes 
saturated at 8 µg of capture DNA. As seen in Fig. 3g, the 
trehalose synthesis rate increases linearly with the total amount 
of pgm and otsA capture DNA (at the 3/2 ratio). This result 
demonstrates the elimination of pathway kinetic limitations by 
maintaining an optimal profile of enzymatic activities.  
Trehalose 6-phosphate is known to inhibit hexokinase in 
Saccharomyces cerevisiae,17-19 and this could explain in part 
the observed results: Increasing OtsA activity leads to trehalose 
6-phosphate accumulation that would, in turn, cause reduction 
 
 
of the production of glucose 6-phosphate and overall pathway 
flux. This effect alone, however, cannot explain the observed 
effects of PGM on the flux or the fact that decreased trehalose 
synthesis is seen at increased OtsB activities. A complete 
explanation of the observed pathway kinetics should be sought 
in an overall flux distribution model derived from individual 
enzymatic kinetics and regulation. It is nevertheless of interest 
to observe that the trehalose synthesis rate increases linearly 
with the total amount of PGM and OtsA enzymes, as long as 
their balance is maintained at the optimal ratio of 3/2. By fixing 
the relative enzyme activities around the branch point, the 
whole pathway can be regarded as an independent linear 
pathway whose flux increases linearly with the activity of the 
pathway enzymes according to Kacser’s “Universal 
Theorem.”20 
 
 
IV. CONCLUSION 
While the focus of this research was on metabolic 
pathway optimization, the chimeric molecules of RNA display 
can have much broader applications. Immobilization of 
functionally active proteins that are usually unavailable but can 
be obtained from genomic information by in vitro translation is 
of importance in the manufacturing of microarrays for protein 
capture for analytical applications (protein microarrays),8,9 
screening of protein libraries for binding to target molecules, 
and screening of peptides or natural products for inhibition of 
binding activity. We also envision applications for the 
production of high added value compounds by reconstructing 
entire pathways for the synthesis of such compounds. 
Examples include proteins with specific glycosylation patterns 
and other post-translational modifications and reactions, in 
general, catalyzed by unavailable enzymes that can be 
produced in vitro from their genomic sequence and 
conveniently immobilized using their capture DNA 
homologue. A particular advantage of the described method is 
the parallel synthesis of many chimeric molecules by in vitro 
translation of all such molecules at the same time. The 
specificity of immobilization by the homologous capture DNA 
molecules simplifies drastically the many purification steps that 
would be needed otherwise.     
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